Lundbeck A S H Net Worth

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Lundbeck H IMRA stock SEC Form 4 insiders trading

Lundbeck has made over 1 trades of the Imara Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Lundbeck bought 85,923,561 units of IMRA stock worth 543,036,906$ on 22 October 2019.

The largest trade Lundbeck's ever made was buying 85,923,561 units of Imara Inc stock on 22 October 2019 worth over 543,036,906$. On average, Lundbeck trades about 42,961,781 units every 0 days since 2019.

You can see the complete history of Lundbeck H stock trades at the bottom of the page.

What's Lundbeck H's mailing address?

Lundbeck's mailing address filed with the SEC is OTTILIAVEJ 9, , VALBY, G7, DK-2500.

Insiders trading at Imara Inc

Over the last 5 years, insiders at Imara Inc have traded over 7,889,059$ worth of Imara Inc stock and bought 11,496,717 units worth 107,874,489$ . The most active insiders traders include David M Mott、Lundbeck A S H、Capital Management, L.P.Ra .... On average, Imara Inc executives and independent directors trade stock every 23 days with the average trade being worth of 1,965,179$. The most recent stock trade was executed by Michael Gray on 22 February 2023, trading 9,856 units of IMRA stock currently worth 46,028$.

What does Imara Inc do?

Imara Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin. Imara is currently advancing IMR-687, a highly selective, potent small molecule inhibitor of PDE9 that is an oral, once-a-day, potentially disease-modifying treatment for sickle cell disease and beta-thalassemia.

Imara Inc executives and stock owners

Imara Inc executives and other stock owners filed with the SEC include:

• Rahul D. Ballal,
  Chief Executive Officer
• Edward R. Conner,
  Director
• Enterprise Associates 14, L...,
  
• Springs Capital Management ...,
  
• Lundbeck A S H,
  10% owner
• City Capital Llc Bay City C...,
  
• Venture Investments, Llc Al...,
  10% owner
• Invest A/S Lundbeckfond,
  10% owner
• Bioscience Plc Arix Bioscie...,
  
• Capital Management, L.P.Ra ...,
  
• Advisors Llc Orbi Med Capit...,
  
• James G Mc Arthur,
  Director
• Carlbay City Capital Llc Ba...,
  
• Mette Kirstine Agger,
  Director
• David P Bonita,
  Director
• Barbara Dalton,
  Director
• Sara M. Nayeem,
  Director
• David M Mott,
  Director
• Inc Pfizer Ventures (Us) Ll...,
  
• Enterprise Associates 14, L...,
  
• Michael Gray,
  CFO & COO
• Kenneth Attie,
  SVP, CMO
• Laura A Williams,
  Director
• Carl Goldfischer,
  Director
• Mark Chin,
  Director
• Advisors Llc Orbi Med Capit...,
  
• Braden Michael Leonard,
  10% owner
• Enterprise Associates 14, L...,
  
• Enterprise Associates 14, L...,
  
• Enterprise Associates 14, L...,
  
• Capital Lp Commodore,
  10% owner